Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N D'Ostilio

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Immunology|June 1, 1996
90K (Mac-2 BP) in human milkN D'Ostilio, G Sabatino, C Natoli, et al.
Anticancer Research|November 1, 1995
Chronomodulated infusion of 5-fluorouracil, folinic acid and carboplatin in colorectal cancer: a pilot studyC Natoli, M T Martino, L Irtelli, et al.
British Journal of Haematology|September 1, 1993
Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patientsG Longo, C Natoli, D Rafanelli, et al.
The American Journal of Gastroenterology|July 1, 1995
Pancreatic juice 90K and serum CA 19-9 combined determination can discriminate between pancreatic cancer and chronic pancreatitisN Gentiloni, P Caradonna, G Costamagna, et al.
Anticancer Research|May 1, 1994
Elevated serum levels of a 90,000 daltons tumor-associated antigen in cancer and in infection by human immunodeficiency virus (HIV)C Natoli, L Ortona, E Tamburrini, et al.
Archives of Pathology & Laboratory Medicine|March 14, 1998
90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10(6) cells/LN Tinari, C Natoli, N D'Ostilio, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Immunology|June 1, 1996
90K (Mac-2 BP) in human milkN D'Ostilio, G Sabatino, C Natoli, et al.
Anticancer Research|November 1, 1995
Chronomodulated infusion of 5-fluorouracil, folinic acid and carboplatin in colorectal cancer: a pilot studyC Natoli, M T Martino, L Irtelli, et al.
British Journal of Haematology|September 1, 1993
Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patientsG Longo, C Natoli, D Rafanelli, et al.
The American Journal of Gastroenterology|July 1, 1995
Pancreatic juice 90K and serum CA 19-9 combined determination can discriminate between pancreatic cancer and chronic pancreatitisN Gentiloni, P Caradonna, G Costamagna, et al.
Anticancer Research|May 1, 1994
Elevated serum levels of a 90,000 daltons tumor-associated antigen in cancer and in infection by human immunodeficiency virus (HIV)C Natoli, L Ortona, E Tamburrini, et al.
Archives of Pathology & Laboratory Medicine|March 14, 1998
90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10(6) cells/LN Tinari, C Natoli, N D'Ostilio, et al.
Pageof 1